Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-014741-89Phase 4Active
Phase 4, open-label, single-arm trial of sufentanil in pain, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: ED90 of sufentanil bolus. Started Aug 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-014741-89.